Genotoxicity of Aflatoxin B1: Evidence for a Recombination-mediated Mechanism in Saccharomyces Cerevisiae

Overview

Journal Cancer Res

Specialty Oncology

Date 1996 Dec 1

PMID 8968101

Citations 12

Authors

C Sengstag

B Weibel

M Fasullo

Affiliations

Soon will be listed here.

Abstract

The potent liver carcinogen aflatoxin B1 (AFB1) is metabolized by cytochrome P450 to the mutagenic epoxide. We have observed that activated AFB1 also strongly induced mitotic recombination in the yeast Saccharomyces cerevisiae. To compare the recombinogenicity of AFB1 to its mutagenicity, three metabolically competent S. cerevisiae strains have been constructed. The frequencies of induced recombinants resulting from gene conversion or chromosomal translocations were determined by different prototrophic selections using two strains, whereas the inducibility of forward mutations was determined by the frequency of drug resistance in the third strain. Human cytochrome P4501A1- (CYP1A) and NADPH-cytochrome P450-oxidoreductase cDNAs were expressed in the strains to ensure intracellular metabolism to the epoxide. Exposure of the strains to AFB1 resulted in a 139- and 24-fold increase in the translocation and gene conversion frequencies, respectively, whereas the mutation frequency was increased only 3-fold. In contrast, benzo[a]pyrene-7,8-dihydrodiol and ethyl methanesulfonate induced mutation and mitotic recombination to similar degrees. We conclude that AFB1 exerted a strong recombinogenic, but only a weak mutagenic, effect. The recombinogenicity of AFB1 in yeast may indicate a mechanism for the high proportion of loss of heterozygosity that has been detected in AFB1-related human liver cancers.

Citing Articles

High-throughput screening of the Saccharomyces cerevisiae genome for 2-amino-3-methylimidazo [4,5-f] quinoline resistance identifies colon cancer-associated genes.

Dolan M, St John N, Zaidi F, Doyle F, Fasullo M G3 (Bethesda). 2023; 13(12).

PMID: 37738679 PMC: 11025384. DOI: 10.1093/g3journal/jkad219.

The continuing evolution of barcode applications: Functional toxicology to cell lineage.

Fasullo M, Dolan M Exp Biol Med (Maywood). 2022; 247(23):2119-2127.

PMID: 36113119 PMC: 9837303. DOI: 10.1177/15353702221121600.

CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae.

Kannan A, Perpetua N, Dolan M, Fasullo M Mutat Res Genet Toxicol Environ Mutagen. 2022; 874-875:503440.

PMID: 35151423 PMC: 10276974. DOI: 10.1016/j.mrgentox.2022.503440.

Genome Profiling for Aflatoxin B Resistance in Reveals a Role for the CSM2/SHU Complex in Tolerance of Aflatoxin B-Associated DNA Damage.

St John N, Freedland J, Baldino H, Doyle F, Cera C, Begley T G3 (Bethesda). 2020; 10(11):3929-3947.

PMID: 32994210 PMC: 7642924. DOI: 10.1534/g3.120.401723.

An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.

Fasullo M, Freedland J, St John N, Cera C, Egner P, Hartog M Environ Mol Mutagen. 2017; 58(4):217-227.

PMID: 28436563 PMC: 5479318. DOI: 10.1002/em.22093.

References

Monroe D, Eaton D . Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse. Toxicol Appl Pharmacol. 1988; 94(1):118-27. DOI: 10.1016/0041-008x(88)90342-0. View

Cariello N, Cui L, Skopek T . In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyltransferase gene. Cancer Res. 1994; 54(16):4436-41. View

Rose A, Broach J . Propagation and expression of cloned genes in yeast: 2-microns circle-based vectors. Methods Enzymol. 1990; 185:234-79. DOI: 10.1016/0076-6879(90)85024-i. View

Shimada T, Nakamura S, Imaoka S, Funae Y . Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes. Toxicol Appl Pharmacol. 1987; 91(1):13-21. DOI: 10.1016/0041-008x(87)90189-x. View

Fujimoto Y, Hampton L, Wirth P, Wang N, Xie J, Thorgeirsson S . Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994; 54(1):281-5. View

Groopman J, Cain L, Kensler T . Aflatoxin exposure in human populations: measurements and relationship to cancer. Crit Rev Toxicol. 1988; 19(2):113-45. DOI: 10.3109/10408448809014902. View

Zhang L, Jenssen D . Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis. 1994; 15(10):2303-10. DOI: 10.1093/carcin/15.10.2303. View

Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View

Tlsty T, Margolin B, Lum K . Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc Natl Acad Sci U S A. 1989; 86(23):9441-5. PMC: 298512. DOI: 10.1073/pnas.86.23.9441. View

10.

Eaton D, Gallagher E . Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol. 1994; 34:135-72. DOI: 10.1146/annurev.pa.34.040194.001031. View

11.

Murakami Y, Hayashi K, Hirohashi S, Sekiya T . Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991; 51(20):5520-5. View

12.

Doehmer J, Dogra S, Friedberg T, Monier S, Adesnik M, Glatt H . Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proc Natl Acad Sci U S A. 1988; 85(16):5769-73. PMC: 281846. DOI: 10.1073/pnas.85.16.5769. View

13.

Rutten A, Falke H, Catsburg J, Wortelboer H, Blaauboer B, Doorn L . Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardization of assay conditions. Arch Toxicol. 1992; 66(4):237-44. DOI: 10.1007/BF02307168. View

14.

Shen H, Ong C, Lee B, Shi C . Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis. 1995; 16(2):419-22. DOI: 10.1093/carcin/16.2.419. View

15.

Martin C, Garner R . Aflatoxin B -oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature. 1977; 267(5614):863-5. DOI: 10.1038/267863a0. View

16.

Fabre F, Roman H . Genetic evidence for inducibility of recombination competence in yeast. Proc Natl Acad Sci U S A. 1977; 74(4):1667-71. PMC: 430853. DOI: 10.1073/pnas.74.4.1667. View

17.

Sengstag C, Wurgler F . DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes. Mol Carcinog. 1994; 11(4):227-35. DOI: 10.1002/mc.2940110408. View

18.

Fasullo M, Dave P, Rothstein R . DNA-damaging agents stimulate the formation of directed reciprocal translocations in Saccharomyces cerevisiae. Mutat Res. 1994; 314(2):121-33. DOI: 10.1016/0921-8777(94)90076-0. View

19.

Kulka U, Doehmer J, Glatt H, BAUCHINGER M . Cytogenetic effects of promutagens in genetically engineered V79 Chinese hamster cells expressing cytochromes P450. Eur J Pharmacol. 1993; 228(5-6):299-304. DOI: 10.1016/0926-6917(93)90064-w. View

20.

Vieira J, Messing J . Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985; 33(1):103-19. DOI: 10.1016/0378-1119(85)90120-9. View